Arkolith/Insider Trading/NRIX/Form 4

Ring Christine

Chief Legal OfficerNurix Therapeutics, Inc. (NRIX) · full profile →Form 4 · filed Apr 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$124K
Net Open-Market Flow
-$124K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Sell(S)8K$15.24$124K26K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001817199-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML